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Abstract
This chapter presents a systematic review of the literature to assess the effec-
tiveness of brief psychological interventions for medically unexplained symptoms 
(MUS)/somatic symptom disorder, non-cardiac chest pain, and illness anxiety 
disorder or health anxiety (HA). Google Scholar, PubMed, and Web of Science 
were searched as data sources. Reference lists were subsequently examined for other 
relevant articles. Studies were assessed according to specified inclusion criteria and 
extracted according to PRISMA guidelines. A total of 23 studies were included in 
the final synthesis. Significant effects for intervention groups relative to control 
groups were reported in 19 studies, whilst 4 studies did not determine any signifi-
cant benefits of interventions compared with controls. All of the brief interventions 
(CBT, psychosocial, psychophysiological, psychosomatic, relaxation and group 
therapy), with the exception of metaphor therapy, showed significant effects rela-
tive to controls in at least one study. The evidence suggests that brief psychological 
interventions, more specifically time limited CBT based interventions may be effec-
tive in treating HA and MUS with psychological distress. Findings are comparable 
with other reviews. Future research may facilitate the piloting of an intervention, 
and there remains a need to provide more robust evidence of cost effectiveness.
Keywords: LICBT, MUS, HA, depression, anxiety
1. Introduction
1.1 Definitions, diagnostic criteria and comorbidities
There has been considerable dispute around the classification and terminologies 
used in relation to medically unexplained symptoms (MUS) and associated syndromes 
[1, 2]. MUS is a general term for syndromes without a known pathological cause. The 
use of the term itself is also often problematic given the negative connotations. Indeed, 
many patients prefer the use of alternative terms, for example ‘persistent physical 
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symptoms’ [3]. The current review assesses the effectiveness of brief interventions for 
MUS, illness anxiety disorder, somatic symptom disorder, health anxiety (HA) and 
non-cardiac chest pain (NCCP). Although there may be a degree of overlap within 
these, it is important to outline what distinguishing features there may be.
Some of the most pronounced revisions within the latest version of the DSM-V 
relate to MUS [4]. A new category (‘Somatic Symptom and Related Disorders’) 
has been created, wherein MUS fits. The category includes diagnoses of Somatic 
Symptom Disorder (SSD) which replaces the term MUS, and Illness Anxiety 
Disorder (IAD) which replaces HA. The term hypochondriasis is no longer referred 
to. The key difference between MUS and SSD is that SSD accounts for cases where 
symptoms may have an underlying pathology, but there remains an exaggerated 
response. However, given that SSD also includes cases where there is an absence 
of pathological cause (i.e. MUS), the term has been included in the current review 
in addition to a specific SSD and NCCP. The terms IAD and HA are both used to 
refer to the preoccupation with having a serious illness; somatic symptoms may 
not be present, or may present in mild form. MUS and IAD may therefore present 
in isolation or comorbidly; this is determined by the presence (or not) of physical 
symptoms without pathological cause, and the subsequent response to these.
Up to one third of individuals with physical heath presentations have MUS [5]. 
The prevalence of MUS within the general population, and more particularly within 
medical settings, is high [6, 7]. MUS and HA are both associated with increased 
costs accrued through frequent and inappropriate use of healthcare services, 
absenteeism and long-term unemployment [8, 9]. It has been estimated that annual 
healthcare service costs resulting from psychosomatic symptoms are approximately 
£3 billion in the UK [10].
1.2 The role of depression and anxiety
Pain is one of the most commonly presented MUS [11]. Physical symptoms are 
highly prevalent in depression and may result in chronic pain and impede treatment 
effectiveness. Depression and pain are influenced by the same neurochemical pro-
cesses, therefore both must be treated simultaneously in order to achieve improve-
ments. Previous research has demonstrated that improvements in depressive 
symptoms was correlated with the improvement of some physical symptoms [12]. 
The prevalence of depression and anxiety among MUS patients has been estimated 
at 70% [11]. The division between services for physical health problems and mental 
health disorders reinforces the notion of body and mind as entirely separate enti-
ties, consequently adding to the psychological distress associated with MUS [13]. 
In relation to NCCP specifically, higher levels of anxiety have been detected among 
individuals with NCCP compared with health individuals [14]. Given that MUS 
and pain have high levels of psychiatric comorbidity, it has been suggested that a 
multidisciplinary intervention strategy may be appropriate [15].
1.3 Psychological interventions: MUS/SSD
Qualitative research has reported that individuals with MUS have a tendency to 
reject psychological constructs of their problems [16], resulting in an unwillingness to 
engage in psychological treatments [8, 17, 18]. However other studies have suggested 
that a significant percentage of these patients would consent to undergo psychological 
or psychiatric interventions [19]. Evidence suggests that cognitive behaviour  
therapy (CBT) is beneficial in the treatment of MUS [20, 21]. A systematic review 
and meta-analysis of non-pharmacological interventions for somatoform disorders 
and MUS in adults determined that psychological therapies irrespective of modality 
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were more beneficial overall than standard care or waiting lists in relation to reducing 
symptoms severity [22]. Fourteen from twenty one studies included in the review and 
subsequent analysis focused on CBT based interventions. CBT was determined to be 
more effective in reducing the severity of MUS, but there was insufficient evidence 
to support the efficacy of other modalities. Furthermore, although there is a robust 
evidence base demonstrating the effectiveness of high intensity CBT for somatoform 
related disorders, there are limited reviews investigating the effectiveness of low 
intensity or brief psychological interventions.
A critical review of 31 controlled clinical trials including 1600 patients where 
CBT was employed as an intervention for somatization and symptoms syndromes, 
found that CBT contributed to the improvement of physical symptoms in 71% 
of studies, functional status in 47% and psychological distress in 38% [23] 
Furthermore, group therapy and brief treatments of 5 sessions were also found to 
be effective, with benefits maintained for up to one year. The review concluded 
that CBT is an effective intervention for this patient population, and that benefits 
were achievable even if psychological distress was not entirely alleviated. Similarly, 
although the focus was not on brief or low intensity treatments, a randomised 
clinical trial comparing an intensive psychodynamic therapy and CBT for patients 
with medically unexplained pain indicated that both groups achieved reductions 
in psychological distress, catastrophic thinking and depression; and interventions 
were deemed to be equally effective at a three month follow up [24]. The CBT group 
however, demonstrated an improvement in self-efficacy that was not observed in 
the other group.
In relation to low intensity (brief) interventions, patients attending an IAPT 
pilot site specifically tailored for long term conditions (LTC)/MUS referrals were 
offered either a low intensity CBT (guided self-help delivered by a Psychological 
Wellbeing Practitioner) based intervention, or a mindfulness-based stress reduc-
tion treatment (brief, low intensity interventions). Subsequent thematic analysis 
of qualitative interviews indicated that patients typically reported a positive treat-
ment experience, and felt better able to manage symptoms, even if this was not 
necessarily reflected by psychometric scores on the Patient Health Questionnaire-9 
(PHQ9), Generalised Anxiety Disorder-7 (GAD7), and the WSAS. Although these 
interventions have been determined as appropriate for these patient groups, it 
has been suggested in terms of evaluation, that routine outcome measures may 
not entirely capture the true benefits of interventions [25]. It is also important to 
consider the clinical implications of these initial findings, namely that there were a 
higher number of LTC referrals compared with MUS. This may be partly explained 
by previous reports that GPs feel inadequate and discouraged when dealing with 
MUS cases [26]. Furthermore, as previously highlighted, research has indicated 
that MUS patients believe there is disparity between their physical symptoms and 
a psychological intervention [27]. The difference in referral rates between LTC 
and MUS patients suggest a need for separate dedicated services for each of these 
patient groups [28].
1.4 Psychological interventions: NCCP
Current reviews of clinical care have highlighted a failure to appropriately man-
age NCCP despite the substantial prevalence rates [29]. Studies to date have pointed 
to the efficacy of CBT [30, 31]. The efficacy of CBT as an intervention for NCCP has 
been evaluated in a number of randomised controlled trials [32]. A comparison of 
CBT and standard clinical advice among NCCP patients found major reductions in 
both the frequency and severity of symptoms in the CBT group, and only modest 
improvements within the control group [13].
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Similarly, an RCT with UCP patients and found that those who had com-
pleted a course of CBT had a significantly higher treatment response when 
compared with placebo and medication groups [30]. A LICBT intervention, 
more specifically ‘coping skills’ resulted in significant improvement relating to 
the catastrophizing of pain symptoms and anxiety when compared to a placebo 
group [33].
Recent research has also emphasised the success of brief cognitive behavioural 
therapy, with a three session CBT intervention determined as effective for UCP 
patients in terms of illness perception [34]. A recent study concluded that a brief 
cognitive behavioural intervention significantly reduced levels of anxiety and 
depression in patients with NCCP, with a diagnosis of panic and/or a depressive 
disorder based on Hospital anxiety and depression scale (HADS) scores [35]. Based 
on these findings, it was recommended that individuals presenting with NCCP 
should be assessed for psychopathology, and a cognitive behavioural intervention 
offered in cases where psychological difficulties are detected. Cognitive behavioural 
interventions as brief as even a single session initiated within two weeks of an emer-
gency attendance for the primary complaint of chest pain, have also been found 
to be effective for panic disorder [36]. Furthermore, it has been recommended 
that increased efforts should be employed to implement these interventions in the 
emergency department/primary care setting, considering the high prevalence of 
panic disorder there.
1.5 Psychological interventions: HA/IAD
A recent systemic review and meta-analysis evaluating CBT for health anxiety 
found a large effect size for CBT compared with several control conditions 
including standard care, waiting lists, medications and other psychological 
therapies [37]. In Van Gils et al. [38], another systematic review and met-analysis 
suggested self-help was associated with significant reduction in symptom sever-
ity and improvement in quality of life measures among individuals with MUS 
[38]. Low intensity interventions which are brief and facilitate flexible delivery 
have been determined as effective for identified health anxiety within medical 
settings [39].
1.6 Aims of the current review
A recent study determined that 58.7% of all chest pain presentations to an ED 
across a three year period resulted in a diagnosis of NCCP [40]. However, care 
pathways and guidance on the most appropriate interventions for this patient 
population are very unclear. To date a consolidated and systematic review has not 
been carried out. In light of these findings, and given the lack of reviews focused 
on brief or low intensity treatments, the purpose of the current review was to assess 
the effectiveness of brief interventions which may be suitable for these particular 
and similar patient populations. Given that there is a high prevalence of MUS 
within primary care with possible associated anxiety, this review sought to examine 
evidence for brief interventions which may in principle, improve ease of access to 
appropriate treatment within a stepped care approach, and be implemented at a 
reduced cost compared with higher intensity or longer term treatments in second-
ary care. To ensure a more robust assessment, conditions which may exist comor-
bidly with NCCP were included. Therefore the current review specifically aimed 
to assess the effectiveness of brief interventions for MUS, illness anxiety disorder, 
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SSD, HA and NCCP, accounting also for the recent changes in terminologies  
and diagnostic criteria within the DSM-V.
2. Method
2.1 Eligibility criteria
Studies were assessed for eligibility for inclusion as per the following criteria: (1) 
written in the English language; (2) published in a journal; (3) included a quantita-
tive evaluation of a brief intervention, with brief defined as ten or fewer individual 
of group based treatment sessions; (4) interventions were aimed at reducing the 
frequency and/or impact of MUS, HA, SSD, illness anxiety disorder, or NCCP; (5) 
participants were over 18 years of age; (6) outcome measures indicated the degree 
of MUS, and/or psychological wellbeing pre and post intervention; and (7) ran-
domised controlled trial, with control group(s).
2.2 Search strategy
Three databases, specifically Google Scholar, PubMed, and Web of Science 
were searched for full-text articles which were published in peer reviewed journals. 
Combinations of the following keywords were used: brief* and intervention*, 
treatment*, therapy*. The key search terms were (1) medically unexplained symp-
toms (2) health anxiety, (3) somatic symptom disorder, (4) illness anxiety disorder 
and (5) non-cardiac chest pain. Table 1 indicates the complete search strategy 
employed in Google Scholar advanced searches, which was subsequently modified 
for the remaining searches. The reference lists of the articles selected from database 
searches were also examined.
2.3 Study selection and data extraction
Studies were selected by (1) screening the titles; (2) screening the abstracts and 
methodologies; (3) reviewing the complete paper if the title, abstract and method-
ologies did not present conclusive evidence that the inclusion criteria were achieved. 
Studies which did not meet inclusion criteria were subsequently disregarded. Data 




c. or brief therapy*
d. and exact phrase medically unexplained symptoms
e. or somatic symptom disorder (exact)
f. or illness anxiety disorder (exact)
g. or health anxiety (exact)





used throughout the searches and the review. This was used specifically to record 
information about study and participant characteristics, details of interventions, 
outcome measures and analyses.
2.4 Risk of bias
The Cochrane Collaboration Risk of Bias Tool was used in order to assess the risk 
of bias in the studies selected for the review. This involved screening for bias risk in 
relation to sequence generation, allocation concealment, blinding of participants 
and assessors, incomplete data, selective reporting and any other relevant bias. Both 
authors independently reviewed the selected studies and subsequently agreed on 
the level of risk of bias as either low, unclear or high.
3. Results
3.1 Study selection
The literature search and search of references from fully screened articles 
yielded a total of 1674 studies. After removal of duplicates the total was 885. 
Figure 1 indicates the process of exclusion and final selection.
3.2 Study characteristics
3.2.1 Location
A summary of the selected studies is presented in Table 2. Studies originated in 
the USA (n = 6), Spain (n = 2), Germany (n = 2), Netherlands (n = 3), UK (n = 4), 
Iran (n = 2), Norway (n = 1), Sweden (n = 1) and Canada (n = 2). In seven of the 
studies, the purpose was to evaluate the effect of interventions on medically unex-
plained symptoms. The remaining studies investigated intervention effects on soma-
tisation (n = 3), health anxiety (n = 2), hypochondriasis (n = 2) and non-cardiac 
chest pain [10]. All studies considered effectiveness in terms of physical symptoms 
and psychological wellbeing.
3.3 Participants
All of the included studies involved both male and female participants, and ages 
ranged from 16 to 81. The total number of participants varied in each of the studies. 
Eleven of the studies included less than 60 participants, 4 studies included between 
61 and 100 participants, 3 studies included between 101 and 150 participants, 4 
studies included between 151 and 200 participants and one study involved 444 
participants.
3.3.1 Sample size
All studies employed selective sampling methods (purposive), whereby poten-
tial participants were initially identified by health professionals prior to subsequent 
additional eligibility screening using diagnostic interview and psychometric 
questionnaires. Five studies concurrently used opportunistic sampling methods 
(through public advertising) prior to the additional screening. Six studies provided 
some details of power calculations made in order to determine optimum sample 
sizes. The remaining studies did not describe how sample size was calculated.
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3.3.2 Unit of allocation and risk of bias
All of the included studies used random allocation to intervention or control 
groups. However, one of these studies [41] did not allocate participants in a conven-
tional way, given that they were not actually randomly assigned to conditions, but 
rather the decision was taken by the authors (for ethical reasons) that the order of 
the three condition cohorts should be randomly predetermined.
3.3.3 Theoretical basis of the interventions
All of the interventions had a psychological basis. Cognitive behavioural therapy 
formed the theoretical basis of the interventions in 17 of the studies. Two studies 
described the intervention as psychosocial and communicative. One study described 
the intervention as psychophysiological, and one study used a brief psychosomatic 
intervention. Two studies used relaxation and metaphor therapies. Interventions 
were delivered as individual sessions in the majority of studies (n = 20), and inter-
ventions were delivered in a group basis in the remaining studies (see Table 2).
3.3.4 Duration
The studies selected for the current review varied in their duration from six 
months to four years.
Figure 1. 
Prisma flow diagram of search results and selected studies.
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[45] Time limited CBT-type 45–60 minutes Maximum of 10 
sessions
CGI-S, CGI-I, VAS, 
MOS-10, HAM-D, 
HAM-A
[50] Psychosocial and 
communication 
intervention
30 minutes Maximum of six 
sessions
MOS, SF-36, CIDI, 
PRIME-MD, SLE, 
NAS
[46] Single session CBT 3–4 hours One session BSI-SOM, SOMS-7
BSI-GSI, WI, BDI, 
KKG-I




[52] Time limited 
psychophysiological 
intervention




[53] Brief multimodal 
psychodynamic therapy
45 minutes Maximum of 9 
sessions
VAS, NHL, 4DSQ , 
SF-36 MAF
[55] Time-limited mindfulness 
cognitive therapy




SHAI, WI, BAI, BDI
[39] Time limited CBT Not specified 5–10 sessions HADS, SFQ-36, 
EQ-5D
[59] Brief psychoeducation 
based on CBT
1 hour 1 face to face 
session and 2 
brief follow-up 
phone calls
BDI, STAI, SF-36, 
WI, SCL-90
[41] Short-term CBT 60–90 minutes Maximum of 3 
sessions
BSQ , SF-36, BDI, 
HRQOL
[62] Relaxation training or 
metaphor therapy
2 hours Maximum of 4 
sessions
BPI, JIBT
[61] Guided internet therapy 
(CBT based)
Not specified Maximum of 4 
sessions
CAQ , BSQ , PHQ-9
[35] Brief CBT 45 minutes Maximum of 6 
sessions
CGI, HADS, MINI, 
STAI, FQ
[60] Brief 1 hour 1 session Chest Pain 
Interview, ASI, 
CAQ , SF-36, BSI
[57] Time limited CBT 90 minutes Maximum of 6 
sessions
WI, HAI, HCQ , SSI, 
FSQ , SCL-90, SIS
[63] Metaphor therapy 2 hours Maximum of 4 
sessions
PDS, DASS,
[58] Brief CBT or 
pharmacological treatment
1 hour Maximum of 7 
sessions
ADIS-IV, ACQ , ASI, 
PAS, BDI, CAQ
[49] Time limited CBT Not specified Maximum of 10 
sessions
CGI-SD, SF-36, SSS




[36] Brief panic management 





ADIS-IV, BSQ , PAS, 
ASI, CAQ , ACQ
[54] Short-term group therapy 2 hours 8 sessions SF-36
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3.3.5 Control conditions
The vast majority of the selected studies (n = 21), employed a ‘treatment as 
usual’ control condition. The remaining 2 studies [42, 43] employed ‘waiting list’ 
control conditions.
3.4 Interventions: Description and impact
3.4.1 MUS/SSD
3.4.1.1 Brief CBT
The cognitive behavioural model considers predisposing, precipitating and 
perpetuating factors [44]. Psychological distress may be triggered and maintained 
in individuals with physical health symptoms via a cycle of inaccurate perceptions, 
avoidance behaviours and subsequent intensification of symptoms. Four of the 
selected studies included brief CBT based interventions targeting MUS/SSD. One 
of these, assessed the effectiveness of a 10 session treatment (averaging 50 min-
utes duration), which had been modified to target somatization problems. More 
specifically it applied relaxation training, emotional awareness, cognitive restruc-
turing (CR) and communication [45]. Another study facilitated a single session 
(3–4 hours) which focused primarily on developing psychophysiological expla-
nations of symptoms, relaxation, cognitions and healthcare use [46]. The third 
of these studies based their brief CBT intervention on the Consequences model 
within which the focus is on the consequences as opposed to the causes of physical 
symptoms; applied techniques aim to alter the consequences of symptoms [47, 48]. 
Participants were offered a maximum of 5, 45 minute sessions. The final study 





[42] Short-term group based 
educational CBT
90 minutes 6 sessions IAS, SDIH, BDI, 
FSS, DAS, QOL, 
DHBQ , NEO-PI
[43] Short-term group 
psychological (CBT based) 
treatment
2 hours 6 sessions HADS, NHL, SIP, 
NHP
SSP: Somatoform Symptoms Scale; BSI-GSI: Global Severity Index; BDI: Beck Depression Inventory; KKG-I: 
‘Internal Control’ Multidimensional Self-Report Questionnaire; WI: Whitely Index; PSC-51: Physical Symptoms 
Checklist; HADS: Hospital Anxiety And Depression Scale; NHL: Nijmegen Hyperventilation List;4DSQ: 
Four-Dimensional Symptom Questionnaire (Distress, Anxiety, Depression, Somatization); MAF: Measure of 
General Functioning; EQ-5D: Health Related Quality Of Life; STAI: State Trait Anxiety Inventory; SCL-90: 
Symptom Checklist; BSQ: Bodily Sensations Questionnaire; HRQOL: Health Related Quality of Life; BPI: Brief 
Pain Inventory; JIBT: Jones Irrational Belief Test; PHQ-9: Patient Health Questionnaire (Depression); CAQ: 
Cardiac Anxiety Questionnaire; FQ: Fear Questionnaire; MINI: Mini International Neuropsychiatric Interview; 
ASI: Anxiety Sensitivity Index; HCQ: Hypochondrial Cognitions Questionnaire; SSI: Somatic Symptoms 
Inventory; FSQ: Functional Status Questionnaire; SIS: Severity of Illness Scale; PDS: Pain Discomfort Scale; 
DASS: Depression, Anxiety, Stress Scale; PAS: Panic, Agoraphobia Scale; ADIS-IV: Anxiety Disorder Interview 
Schedule; SSS: Severity of Somatic Symptom Scale; GHQ: General Health Questionnaire; SUI: Summary Utility 
Index; ACQ: Agoraphobic Cognitions Questionnaire; IAS: Illness Attitude Scale; SDIH: Structured Diagnostic 
Interview, Hypochondriasis; FSS: Fear Survey Schedule; DAS: Dysfunctional Attitude Scale; QOL: Quality of Life 
Questionnaire; DHBQ: Dysfunctional Health Beliefs Questionnaire; NEO-PI: Personality Inventory; SIP: Sickness 
Impact Profile; NHP: Nottingham Health Profile.
Table 2. 
Key characteristics of selected studies.
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assessing brief CBT for MUS, offered a 10 session manualized intervention adapted 
for somatization disorder aimed at coping with stress and physical discomfort [49].
Of the five studies which implemented brief CBT interventions targeting 
MUS/SSD, significant effects were observed in three whereby the intervention 
was deemed to be effective relative to control groups. No significant effects were 
observed in one study. One study reported medium effect sizes, and found that the 
intervention group had a higher percentage of patients with ‘very much’ or ‘much’ 
improved physical symptoms as reported by blinded evaluators (60% vs. 25.8% 
odds ratio = 4.1; 95% CI, 1.9–8.8; p < .001). There was a significant improvement 
in the intervention vs. the control group (p < 0.5) for depressive symptoms. Effects 
however were no longer noticeable at six month follow-up [45]. Small to medium 
effect sizes were observed in another study and a stronger effect size was detected 
for the intervention group in relation to reduction of doctors’ visits (ŋ2 = 0.031), 
and the reduction of somatization severity (ŋ2 = 0.048). Although significant 
improvements in all other measures were observed for both groups, all participants 
were still highly impaired with the degree of somatization, health anxiety and 
depression all above clinical thresholds at a six month follow-up. [46]. One study 
observed large effect sizes and found that somatization symptoms were signifi-
cantly improved in the intervention group relative to the control group (p < 0.01), 
with the intervention also associated with improved self-reported functioning [49] 
The remaining study determined that the intervention was not more effective than 
care as usual, although approximately 30% of participants in both groups demon-
strated improvements on the clinically relevant outcomes [47].
3.4.1.2 Brief psychosocial interventions
Two of the included studies used psychosocial and communication interven-
tions targeting MUS/SSD. One study trained GPs to explain symptoms in a physi-
cal tangible way as result of hormone imbalance, to subsequently attribute this 
imbalance to irrational thinking, and to explore psychosocial issues indirectly. 
Participants were offered six sessions of 30 minutes [50].
Similarly, the second study trained GPs to gather a thorough psychosocial history, 
evaluate subjective understanding, demonstrate empathy, explain the relationship 
between symptoms and emotional distress, use symptom diaries, identify stressors 
and develop new behaviours; six 20 minute sessions were offered [51].
The first study, observed small to medium effect sizes and large effects sizes 
for bodily pain, social and emotional functioning, and mental health [50]. More 
specifically, quality of life dimensions in the intervention group were significantly 
improved relative to the control group in relation to several SF-36 subscales, 
namely bodily pain (p < 0.03), mental health (p < 0.063), physical functioning 
(p < 0.01), vitality (p < 0.039), social functioning (p < 0.033), and utility index 
(p < 0.039). The second study [51] found significant improvements were observed 
for the intervention group relative to the control group in relation to a reduction of 
physical symptoms (p = 0.07), reduction of depression (p = 0.211) and reduction 
of anxiety (p = 0.388). Effect sizes however were modest and were not maintained 
at six month follow up.
3.4.1.3 Brief psychophysiological interventions
One of the selected studies used a brief psychophysiological intervention targeting 
MUS/SSD. This was a ten session manualized treatment designed specifically for MUS; 
it was described as a treatment to assist with stress and physical discomfort, and spe-
cific components were emphasised depending on individual symptoms profiles [52].
11
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3.4.1.4 Brief multimodal psychosomatic therapy
One study used a brief multimodal psychosomatic therapy targeting MUS. The 
treatment is based on the biopsychosocial model and involved relaxation, mindful-
ness, CBT techniques and activation therapy; up to 9 sessions of 45 minutes dura-
tion were offered [53].
At 12 months post intervention, improvement in perceived symptom severity 
was observed [adjusted mean difference −2.0, 95% confidence interval (CI) −3.6 
to −0.3], in somatization (adjusted mean difference −4.4, 95% CI −7.5 to −1.4) and 
in symptoms of hyperventilation (adjusted mean difference −5.7, 95% CI −10.5 
to −0.8). Although the small sample size was deemed to be efficient, the authors 
concluded that a larger trial would be helpful and feasible. This pilot trail was not 
powered to indicate treatment effect size.
3.4.1.5 Brief group therapy
One study, implemented a short-term group therapy for MUS/SSD (8 sessions 
of 2 hour durations), within which the aims were to develop peer support, share 
coping strategies and improve perceptions and expressions of emotions [54].
In relation to a brief group therapy, the intervention group demonstrated 
significant improvements compared with the control group on both physical health 
(p < 0.05), and mental health (p < 0.01) at post-treatment and at 12 month follow-
up. Treatment effect sizes were not indicated.
3.4.2 HA/IAD
3.4.2.1 Brief CBT
Four of the included studies implemented brief CBT interventions targeting 
HA/IAD. The first offered 5–10 sessions of brief CBT which had been adapted for 
HA [39]. Similarly, another of the studies, employed a 6 session individualised 
intervention which was designed specifically to target and restructure hypochon-
drial thoughts [9]. One study implemented a time-limited group mindfulness-
based CBT intervention, which was described a skills training programme 
adapted for HA [55–56]. A group based intervention was also employed in 
another study. This took the form of an educational course aimed at improving 
coping skills for HA, focused specifically on selective attention, muscle  
tension, breathing, environmental factors, stress, mood and explaining somatic 
symptoms [42].
Four of the included studies implemented brief BCT interventions targeting 
HA/IAD and all reported significant effects for intervention groups relative to con-
trol groups. More specifically, one determined small effect sizes, and found that at 
12 month follow-up point, the intervention group demonstrated an improvement in 
health anxiety symptoms which was 2.98 points greater than the control group and 
these symptomatic improvements were maintained at 2 years follow up. However, 
there were no significant differences between groups in relation to social function-
ing or health related quality of life [39]. At a 12-month follow-up, another study 
found significantly lower levels of hypochondriacal symptoms, beliefs, and atti-
tudes (P < .001) and health-related anxiety (P = .009). in the intervention group. 
Furthermore significantly less impairment of social role functioning (P = .05) and 
intermediate activities of daily living (P < .001) were also observed. Effect sizes 
were reported as small to medium and hypochondriacal somatic symptoms were 
not improved significantly by treatment. The third of these studies determined 
Psychosomatic Medicine
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medium effect sizes; their intervention group demonstrated significantly lower 
health anxiety than the control group both immediately following treatment 
(d = 0.48), and at a 12 month follow-up (d = 0.48) [55]. In the final study significant 
improvement was observed in the intervention group relative to the control group 
on all measures including physical symptoms (p = 0.03), dysfunctional health 
beliefs (p = 0.02), vulnerability (p = 0.03) and lack of control (p = 0.06); effect 
sizes were not reported [42].
3.4.3 NCCP
3.4.3.1 Brief CBT
Seven of the selected studies involved brief CBT based interventions target-
ing NCCP. One of these implemented a 7 session treatment which incorporated 
psychoeducation on chest pain, panic disorder (PD), exposure and CR [58]. 
Two interventions were evaluated in another study [36], namely a single session 
panic management intervention and a 7 session CBT treatment for NCCP and 
PD [36]. Another also trialled a single individualised information session with 
psychoeducational materials [59] One study used a single session of brief CBT 
(60 minute duration) which included psychoeducation, breathing exercises and 
CR [62]. Psychoeducation was again a component of the intervention offered 
in another of the studies, which also included CR, and strategies to influence 
avoidance behaviours over 6 sessions of 45 minutes [35]. One study offered a 3 
session programme (60–90 minutes) which focuses on the CBT model of panic 
and exposure therapy [41]. Guided brief CBT was delivered online in another 
study and involved 4 sessions of psychoeducation, physical activity advice and 
relaxation [61].
Of the seven selected studies which implemented brief CBT based interventions 
targeting NCCP, five reported significant effects for interventions relative to 
control groups and two observed no significance. Large treatment effect sizes 
were observed in one study; both intervention groups demonstrated significant 
improvements relative to the control group in relation to the severity of panic 
disorder (p = 0.12), frequency of panic (p = 0.48), and depressive symptoms 
(p = 0.27) [58]. Similarly large effect sizes were also observed in another study; 
both interventions also achieved significant reductions in the severity of panic 
disorder relative to the control group (ŋ2 = 0.07), although no superiority was 
demonstrated by one intervention as compared with the other [36]. Medium 
effect sizes with significant improvements for the intervention versus control 
in relation to frequency and fear of chest pain, and anxiety sensitivity, but not 
in relation to severity of chest pain, quality of life and psychological distress 
were determined on one study [60]. In another study, significant improvements 
were observed for intervention versus control group in relation to reduction 
of disease severity, anxiety and depression symptoms but effect sizes were not 
determined [35]. A brief CBT intervention was effective compared to care as 
usual and reported medium to large effect sizes. Significant differences were 
observed for fear of bodily sensations, avoidance of physical activities and 
depression. However, the sample size was small and no power analysis was 
carried out [41]. Another study concluded that although improvements were 
demonstrated by both intervention and control groups in relation to cardiac 
anxiety, fear of bodily sensations and depression, no significant differences 
were observed between the groups [61]. Similarly, the remaining study found 
that although both groups achieved slight improvements on the main outcomes, 
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specifically chest pain, mood and limitation of activities, no significant effects 
were observed [59].
3.4.3.2 Relaxation and metaphor therapy
Two studies evaluated relaxation and metaphor therapies targeting NCCP 
[62, 63]. Both treatments consisted of 4 2 hour sessions. The relaxation therapy 
was group based involving learning and practising relaxation and breathing 
techniques. Metaphor therapy involved challenging and connecting metaphoric 
stories of hopelessness, with the ultimate goal of challenging unhelpful beliefs.
The first of these reported small to medium effect sizes, and determined signifi-
cant differences between the relaxation group and both control groups for hopeless-
ness (DM = 9.79, p < 0.05), pain severity (DM = 1.96, p < 0.05), and emotional 
irresponsibility (DM = 4.80, p < 0.05). No significant effects were observed in 
relation to the metaphor therapy intervention group [62]. The subsequent study 
assessed the effectiveness of metaphor therapy only, and again determined no 
significant treatment effects relative to the control group [63].
3.4.3.3 Short-term group therapy
One study implemented a short-term (8 session of 2 hours) group therapy for 
NCCP within which the focus was on sharing experiences and coping strategies, 
education on chest pain, relaxation and breathing exercise, physical exercise, CR 
and graded exposure [43]. Significant improvements were observed in the interven-
tion group relative to the control group in relation to chest pain episodes (p < 0.01) 
and anxiety and depression (p < 0.05), with benefits maintained at a six month 
follow-up. Treatment effect sizes were not indicated.
3.5 Delivery of the intervention
Therapists trained specifically in the relevant interventions were used in eleven 
of the studies. Primary care physicians (GPSs) delivered interventions in four of 
the studies, and four of the studies used clinical psychologists to deliver treatments 
Cardiac nurses delivered interventions in two studies.
3.6 Outcome measures
Several combinations of primary and secondary outcome measures including 
questionnaires and diagnostic interviews were used in the selected studies at pre, 
post and follow-up points. The measures assessed medically unexplained symp-
toms, mental health, health related quality life and general functioning. The most 
frequently used outcome measure was the MOS SF-36 (medical outcomes study 36 
item short-form health survey), which was used in ten of the selected studies. A 
full list of the outcome measures used in each of the included studies is presented in 
Table 2. Intervention effects are presented in Table 3.
3.7 Pre, post and follow-up data
The majority of the studies (n = 17) included in the review adapted longitudinal 
designs and evaluated outcomes at pre and post intervention points and at one or 
more follow-up points. Six of the included studies evaluated outcomes at pre and 




[45] Time limited CBT type therapy 
delivered in primary care 
for patients with medically 
unexplained physical symptoms
The intervention group had a higher percentage 
of patients with ‘very much’ or ‘much’ improved 
physical symptoms as reported by blinded evaluators 
(60% vs. 25.8% odds ratio = 4.1; 95% CI, 1.9–8.8; 
p < 0.001). There was a significant improvement 
in the intervention vs. the control group (p < 0.5) 
for depressive symptoms. Effects were no 
longer noticeable at six month follow-up. Effect sizes 
medium.
[50] A psychosocial and communication 
intervention delivered by GPs 
for patients with medically 
unexplained symptoms.
Improvements in all dimensions of the SF-36 were 
demonstrated by patients in both groups. The 
intervention group demonstrated significantly more 
improvement in bodily pain, mental health, physical 
functioning, social functioning and vitality (p < 0.039). 
Effect sizes: small to medium (large effect sizes for 
bodily pain, social and emotional functioning and 
mental health).
[46] A one session CBT intervention for 
medically unexplained symptoms 
delivered by clinical psychologist
There was a stronger effect size in the intervention 
group in relation to reduction of doctors’ visits 
(ŋ2 = 0.031), and the reduction of somatization 
severity (ŋ2 = 0.048). Although significant 
improvements in all other measures were observed 
for both groups, all participants were still highly 
impaired with the degree of somatization, 
health anxiety and depression all above clinical 
thresholds at a six month follow-up. Effect sizes: small 
to medium
[47] Cognitive behavioural treatment 
delivered by family physician for 
medically unexplained symptoms
The intervention was not more effective than care 
as usual; approximately 30% of participants in both 
groups demonstrated improvements on the clinically 
relevant outcomes. No significance observed: 
intervention not effective as compared with control 
group. Effect sizes: N/A.
[52] Psychophysiological treatment 
(described to participants as an 
intervention to assist in coping 
with physical comfort and distress) 
delivered by psychologists
There was a significantly greater improvement in 
the frequency and severity of physical symptoms 
in the interventions group (p < 0.05). Effect 
sizes also indicated a greater improvement in 
the interventions group for depression symptoms 
(d = 0.81)
[53] Brief multimodal psychodynamic 
therapy for medically unexplained 
symptoms delivered by trained 
practitioners.
Significant differences between groups were observed 
at 12 month follow up; the intervention group 
demonstrated greater improvement in perceived 
symptom severity, somatization and hyperventilation. 
Effect sizes: unknown (trial not powered to indicate 
treatment effect sizes)
[55] Time-limited mindfulness-based 
cognitive therapy for health anxiety 
delivered by trained practitioners 
and clinicians.
The intervention group demonstrated significantly 
lower health anxiety than the control group both 
immediately following treatment (d = 0.48), and 
at a 12 month follow-up (d = 0.48). Effect sizes: 
medium
[39] CBT for health anxiety delivered by 
trained health professionals
At a 12 month follow-up point, the intervention group 
demonstrated an improvement in health anxiety 
symptoms which was 2.98 points greater than the 
control group. Significance observed: intervention 
effective as compared with control group. Effect sizes 
small
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Study Intervention Outcomes
[59] Brief psychoeducational and 
cognitive behavioural intervention 
for non-cardiac chest pain, 
delivered by cardiac nurses
Although both groups achieved slight improvements 
on the main outcomes, specifically chest pain, mood 
and limitation of activities, no significant effects were 
observed. Effect sizes: NA
[41] Short-term CBT for non-cardiac 
chest pain delivered by trained 
therapists.
The intervention was effective compared to care as 
usual; significant differences were observed for fear of 
bodily sensations, avoidance of physical activities and 
depression. Effect sizes medium to large
[63] Relaxation training versus 
metaphor therapy for non-cardiac 
chest pain delivered by clinical 
psychologists.
There were significant differences observed between 
the relaxation group and both control groups for 
hopelessness (DM = 9.79, p < 0.05), pain severity 
(DM = 1.96, p < 0.05), and emotional irresponsibility 
(DM = 4.80, p < 0.05).
Effect sizes small to medium.
[61] Guided internet therapy (CBT 
based) for non-cardiac chest pain 
delivered by cardiac nurses
Although improvements were demonstrated by both 
groups in relation to cardiac anxiety, fear of bodily 
sensations and depression, no significant differences 
were observed between the groups. No significance 
observed.
Effect sizes: N/A
[35] Brief CBT for non-cardiac chest 
pain with associated depression 
and panic disorder delivered by 
clinical psychologists
Significant improvements were observed for 
intervention versus control group in relation to 
reduction of disease severity, anxiety and depression 
symptoms. Effect sizes: unknown (trial not powered to 
indicate treatment effect sizes.
[60] Brief CBT for non-cardiac chest 
pain
Significant improvements were observed for 
intervention versus control in relation to frequency 
and fear of chest pain, and anxiety sensitivity, but not 
in relation to severity of chest pain, quality of life and 
psychological distress.
Effect sizes: medium
[57] CBT for hypochondriasis delivered 
by trained therapists
Significant differences were observed for the 
intervention group versus control group in relation to 
hypochondrial symptoms, beliefs and attitudes, health 
anxiety, and social functioning. Effect sizes: small to 
medium
[63] Metaphor therapy for non-
cardiac chest pain delivered by 
psychologists
There were no significance differences demonstrated 
by the intervention group compared with control group 
on any of the outcome variables (depression, anxiety, 
stress and pain discomfort). No significance observed: 
intervention not effective as compared with control 
group
Effect sizes: NA
[58] Brief CBT or pharmacological 
treatment for non-cardiac chest 
pain with associated panic disorder 
delivered by psychologists.
Both intervention groups demonstrated significant 
improvement relative to the control group in relation to 
the severity of panic disorder (p = 0.12), frequency of 
panic (p = 0.48), and depressive symptoms (p = 0.27). 
Effect sizes large.
[49] Time limited CBT for somatization 
disorder
Somatization symptoms were significantly improved 






4.1 Summary of evidence
This is the first systematic review which examined evidence for brief or 
time-limited interventions for both MUS/SSD, HA/IAD and NCCP specifically. 
Significant effects for the intervention groups relative to control groups were 
reported in 19 studies, and 4 studies did not determine any significant benefits of 
interventions compared with control groups. Significant effects relative to controls 
were determined for all of the brief interventions in at least one study (CBT, psycho-
social, psychophysiological, psychosomatic, relaxation and group therapy), with the 
exception of metaphor therapy for which no significant effects were reported. [63]. 
Of those studies reporting significance, large treatment effects were reported in 3 
[39, 49, 58], medium effect sizes were reported by 3 [45, 55, 60], medium to large 
effects were reported in 2 [34, 52], four studies observed small to medium effect 
sizes [46, 50, 57, 62], and small effect sizes were determined in 2 [39, 51]. Five studies 
did not indicate effect sizes (see Table 3). All of the studies within which the largest 
effect sizes were reported, involved brief CBT for either MUS or NCCP [36, 49, 58].
Study Intervention Outcomes
[51] Psychosocial intervention for 
somatising patients delivered by 
general practitioners
Significant improvements were observed for the 
intervention group relative to the control group in 
relation to a reduction of physical symptoms (p = 0.07), 
reduction of depression (p = 0.211) and reduction of 
anxiety (p = 0.388). Effects were not maintained at six 
month follow up. Effects not maintained at 6 month 
follow-up.
Effect sizes small
[36] Brief psychological interventions 
(panic management and CBT) for 
panic disorder with non-cardiac 
chest pain delivered by trained 
therapists.
Both interventions demonstrated significant reductions 
in the severity of panic disorder relative to the control 
group (ŋ2 = 0.07) although no superiority was 
demonstrated by one intervention as compared with 
the other. Effect sizes large (time)
[54] Short-term group therapy for 
somatization disorder delivered by 
trained therapists
The intervention group demonstrated significant 
improvements relative to the control group on 
both physical health (p < 0.05), and mental health 
(p < 0.01) at post-treatment and at 12 month follow-up. 
Effect sizes: Unknown (trial not powered to indicate 
treatment effect sizes
[42] Short-term group therapy (CBT 
based) for hypochondriasis 
delivered by trained therapists
Significant improvements were observed in the 
intervention group relative to the control group on all 
measures including physical symptoms (p = 0.03), 
dysfunctional health beliefs (p = 0.02), vulnerability 
(p = 0.03) and lack of control (p = 0.06). Effect sizes 
unknown (trial not powered to indicate treatment 
effect sizes
[43] Time limited group psychological 
treatment for non-cardiac chest 
pain delivered by trained therapists
Significant improvements observed in the intervention 
group relative to the control group in relation to chest 
pain episodes (p < 0.01) and anxiety and depression 
(p < 0.05), with benefits maintained at a six month 
follow-up. Effect sizes: Unknown (trial not powered to 
indicate treatment effect sizes.
Table 3. 
Summary of results for included studies.
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There are several possible explanations for the lack of effect on medically 
unexplained symptoms and psychological wellbeing in the trials within which no 
significance was observed. The findings specifically, that time limited CBT deliv-
ered by GPs for MUS did not result in significantly better outcomes than care as 
usual, are consistent with other research which has outlined the limited feasibility 
and effectiveness of CBT for MUS delivered by primary care doctors [47, 64, 65].
Although it was found that brief online CBT guided by cardiac nurses was feasible 
for NCCP given that it decreased cardiac anxiety, frequency of chest pain and depres-
sion symptoms, no significant differences were observed relative to the control group 
[61]. These findings were comparable with another study where no significant treat-
ment effects were determined after a brief single session CBT intervention for NCCP 
again delivered by cardiac nurses [59]. Authors of both studies have highlighted the 
limitations of small sample sizes and recruitment difficulties, possibly due to the fact 
that patients found it difficult to reject a physical explanation for the cause of chest 
pain. As outlined earlier, previous research has suggested that individuals with MUS 
have a tendency to reject psychological constructs of their problems resulting in an 
unwillingness to engage in psychological treatments [8, 16–18].
Regarding the use of metaphor therapy for NCCP after which no significant 
benefits were observed in terms of discomfort, anxiety or depression, the authors 
suggested that the nature of the intervention itself may not be suitable given that it 
is dependent on an individual’s ability to visualise [62, 63]. However, some evidence 
exists to support the use of this intervention, and it was a component of a group 
psychological intervention for NCCP included in the current review within which 
significant treatment effects were observed [43].
Some included studies reported significant treatment effects compared with 
controls after brief CBT for MUS/SSD [45, 46, 49]. As previously highlighted, 
findings in one indicated a more marked reduction in the amount of doctor’s visits 
and in the severity of somatization in the CBT group compared with the standard 
care group [46]. Although actual treatment effects were smaller for this single 
session intervention when compared with more intensive CBT approaches, brief 
interventions still facilitate the treatment of a greater number of MUS patients. It 
has been suggested that brief intervention could improve the general management 
of MUS at the primary care level and subsequently aid access to more special-
ist interventions if clinically required. Furthermore, the importance of early 
intervention should be highlighted given that the condition becomes much less 
manageable and complex over time [9]. It has been suggested that a brief treat-
ment such as a single session CBT/LICBT intervention could be an appropriate 
and effective first point of treatment within a stepped care approach in order to 
improve management of MUS [46, 66].
4.2 Variations in outcomes
Differences in the outcomes observed in the selected studies, may be a result of 
variations in the components and theoretical frameworks of the interventions, the 
duration of the interventions, sampling issues, the selection strategies employed to 
recruit participants, the outcome measures used to determine MUS and psychologi-
cal wellbeing, the experience levels of persons delivering the interventions, and 
how data was collected and analysed.
The psychological framework of the interventions evaluated in the selected 
studies included CBT, psychosocial, psychosomatic, relaxation, metaphor, and gen-
eral group therapy. Significant effects at the post-intervention stage (at least), were 
reported by all included studies except 3 studies which implemented brief CBT, and 
2 studies which implemented brief metaphor therapy.
Psychosomatic Medicine
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However, 13 studies did determine significant effects for brief CBT, as did both 
studies which used psychosocial treatments. Furthermore each of the single studies 
evaluating either psychosomatic, relaxation or general group therapy also reported 
significance. It is not possible therefore to concretely conclude if one of these brief 
interventions might offer superior benefits to the other, given the more limited 
available outcomes from trials assessing interventions other than those which are 
CBT based. Rather, it may concluded that some evidence exists to support the use 
of all of the interventions for medically unexplained symptoms and associated 
psychological distress, with the exception of metaphor therapy. More specifically 
there is substantial evidence within the current review supporting the use of brief/
time-limited CBT, and existing but more limited evidence supporting the use of the 
remaining included interventions.
Several studies highlighted issues with sampling and sampling size, which might 
have influenced outcomes. Despite screening 6409 potential participants, only 65 
were included in the trial for one study [47]. Some were excluded due to a natural 
reduction of symptoms or due to the presence of severe and comorbid conditions. 
Chronic issues with somatization are likely to follow a path of highs and lows in 
relation to the severity of and response to symptoms, much like depression and 
anxiety disorders, however, a majority of eligible participants declined the interven-
tion as they had ‘accepted’ symptoms were part of their life.
As indicated earlier, there was a large variation in sample size in the selected 
studies. Eleven of the studies included 60 or fewer participants, and one study 
included 444 participants. Given that the power of the study may be affected by 
a sample which is either too large or small, it is reasonable to suppose that at least 
some of the included studies may have been under-powered to clearly indicate 
between-group differences of statistical significance [67, 68].
The selection of an appropriate outcome measure is an important consid-
eration which can impact the value of results from clinical studies. Selection of 
measures has tended to concentrate more on the psychometric properties, but 
less on the actual suitability of the instruments for their intended purpose. It has 
been suggested that in addition to an evaluation of basic psychometric proper-
ties, researchers should consider that different instruments may capture different 
aspects of complex phenomena and may therefore not be equally valid for everyone. 
Furthermore, a good fit between the measure and what the researcher expects to 
change post treatment is required to facilitate a valid interpretation of the out-
comes. As indicated earlier, a considerably large variety of primary and secondary 
outcome measures were included in the selected studies, and it may be the case that 
not all of those were the optimum instruments [69].
The interventions evaluated in the selected studies were delivered by either 
therapists who had been trained specifically in the relevant interventions, GPs, 
clinical psychologists, or cardiac nurses. Both studies using cardiac nurses 
reported no significant intervention effects, and 2 of the 4 studies within which 
interventions were delivered by GPs also reported no significant intervention 
effects. A systematic review and meta-analysis of randomised controlled tri-
als of psychological treatments found psychological interventions were more 
beneficial when delivered by psychotherapists compared with GPs, and more 
specifically that psychotherapists had a greater effect on physical symptoms than 
GPs [70]. An earlier systematic review considered the prevalence of medically 
unexplained physical symptoms, the extent of comorbidity with psychiatric 
disorders, the importance of psychological processes and the effectiveness of 
interventions. It was reported that there was significant overlap between symp-
toms and syndromes, and that patients with MUS should therefore be considered 
as having complex adaptive systems within which cognitive, physiological and 
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environmental factors interact. CBT and antidepressants are effective, however 
these benefits are heightened when patients feel empowered by their own doctors 
to address their problems [71]. The importance of the GP role was consequently 
highlighted i.e. to validate the patient experience, provide positive and empower-
ing explanations of symptoms and to offer evidence based interventions including 
CBT. Further research has suggested that GP-patient interactions did impact 
consultation and communication patterns but did not subsequently impact 
patient outcomes [72].
It is also important to acknowledge that while the current review focused on 
time-limited intervention, the duration of the course of treatments evaluated in 
the included studies ranged from a single session to ten sessions, with sessions also 
varying in length in addition to varying times between sessions, and the point 
at which follow up data was collected. The potential impact of this on outcomes 
cannot be disregarded. In order to reach more robust conclusions regarding the 
confounding factors which impact clinical outcome in MUS, larger sample sizes and 
longer follow –ups should be employed, given the effects of clustering and generally 
modest effects observed.
There are other methodological issues to consider including that there a were 
variety of methodologies employed in relation to data analysis. Not all of the 
included studies reported specifically how data was cleaned or how missing data 
was handled, and there is a possibility this may account for variability between 
outcomes. Furthermore, some studies employed power analysis and reported 
effect sizes, and some did not. It is therefore recommended that any future trial 
addresses this methodological weakness in order to improve and determine the 
most effective treatment.
4.3 Risk of bias
All of the included studies employed random allocation to intervention or con-
trol group, although many lacked precise details regarding how this was achieved, 
and the risk of bias remained unclear in several studies.
4.4 Strengths and limitations
The main strength of this systematic review is the focus on brief interventions 
which are feasible to offer as part of a stepped care approach. A limitation is that the 
included studies were screened by only one author (except for risk of bias examina-
tion), increasing the possibility that a study might have been missed.
5. Conclusion
The evidence suggests that brief psychological interventions, more specifically 
time limited BCT based interventions may have small to large effects in reduc-
ing the severity of MUS and associated psychological distress. These findings are 
comparable with other reviews which have assessed the efficacy of higher intensity 
and/or longer term interventions. Given that there is a broad range of symptom 
severity and willingness to engage in psychological treatments among MUS patients 
in primary care, it is reasonable to suggest that a stepped care approach may be 
suitable thereby facilitating a more specialist intervention in chronic cases [73–75]. 
However, there remains a need to provide more robust evidence of cost effective-
ness is relation to mild and moderate cases for which briefer interventions such as 





School of Psychology, Ulster University, United Kingdom
*Address all correspondence to: om.mcdevitt-petrovic@ulster.ac.uk
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
21
Assessing the Effectiveness of Brief and Low Intensity Psychological Interventions for Medically…
DOI: http://dx.doi.org/10.5772/intechopen.93912
References
[1] Salmon P. Conflict, collusion or 
collaboration in consultations about 
medically unexplained symptoms: 
the need for a curriculum of medical 
explanation. Patient education and 
counseling. 2007 Aug 1;67(3):246-54.
[2] Creed FH, Davies I, Jackson J,  
Littlewood A, Chew-Graham C, 
Tomenson B, Macfarlane G, Barsky A, 
Katon W, McBeth J. The epidemiology 
of multiple somatic symptoms. Journal 
of psychosomatic research. 2012 Apr 
1;72(4):311-7.
[3] Marks EM, Hunter MS. Medically 
unexplained symptoms: an acceptable 
term?. British journal of pain. 2015 
May;9(2):109-14.
[4] American Psychiatric Association. 
Diagnostic and statistical manual of 
mental disorders (DSM-5®) (2013) 
American Psychiatric Pub. https://doi.
org/10.1176/appi.books.9780890425596
[5] Kirmayer LJ, Groleau D, Looper KJ,  
Dao MD. Explaining medically 
unexplained symptoms. The 
Canadian journal of psychiatry. 2004 
Oct;49(10):663-72.
[6] Creed F, Barsky A. A systematic 
review of the epidemiology 
of somatisation disorder and 
hypochondriasis. Journal of 
psychosomatic research. 2004 Apr 
1;56(4):391-408.
[7] Gureje O, Üstün TB, Simon GE. 
The syndrome of hypochondriasis: 
a cross-national study in primary 
care. Psychological Medicine. 1997 
Sep;27(5):1001-10.
[8] Nezu AM, Nezu CM, Lombardo ER.  
Cognitive-behavior therapy for 
medically unexplained symptoms: 
a critical review of the treatment 
literature. Behavior Therapy. 2001 Jun 
1;32(3):537-83.
[9] Barsky AJ, Orav EJ, Bates DW.  
Somatization increases medical 
utilization and costs independent of 
psychiatric and medical comorbidity. 
Archives of general psychiatry. 2005 
Aug 1;62(8):903-10.
[10] Department of Health. No health 
without mental health: a cross-
government mental health outcomes 





[11] Department of Health. No health 
without mental health: a cross-
government mental health outcomes 





[12] Trivedi MH. The link between 
depression and physical symptoms. 
Primary care companion to the Journal of 
clinical psychiatry. 2004;6(suppl 1):12.
[13] Mayou RA, Bryant BM, Sanders D, 
Bass C, Klimes I, Forfar C. A controlled 
trial of cognitive behavioural therapy for 
non-cardiac chest pain. Psychological 
medicine. 1997 Sep;27(5):1021-31.
[14] Smeijers L, van de Pas H, Nyklicek I, 
Notten PJ, Pedersen SS, Kop WJ. The 
independent association of anxiety with 
non-cardiac chest pain. Psychology & 
health. 2014 Mar 4;29(3):253-63.
[15] Von Korff M, Crane P, Lane M, 
Miglioretti DL, Simon G, Saunders K, 
Stang P, Brandenburg N, Kessler R. 
Chronic spinal pain and physical–mental 
comorbidity in the United States: 
results from the national comorbidity 




[16] Chew-Graham C, Brooks J, 
Wearden A, Dowrick C, Peters S. Factors 
influencing engagement of patients 
in a novel intervention for CFS/ME: 
a qualitative study. Primary health 
care research & development. 2011 
Apr;12(2):112-22.
[17] Shaw, J., & Creed, F. The cost of 
somatization. Journal of psychosomatic 
research, 35(2), 307-312. 1991 https://
doi.org/10.1016/0022-3999(91)90085-3
[18] Sumathipala A. What is the 
evidence for the efficacy of treatments 
for somatoform disorders? A critical 
review of previous intervention studies. 
Psychosomatic medicine. 2007 Nov 
1;69(9):889-900.
[19] Speckens AE, Van Hemert AM, 
Bolk JH, Rooijmans HG, Hengeveld MW. 
Unexplained physical symptoms: 
outcome, utilization of medical care 
and associated factors. Psychological 
medicine. 1996 Jul;26(4):745-52.
[20] Malouff, J. M., Thorsteinsson, E. 
B., Rooke, S. E., Bhullar, N., & Schutte, 
N. S. Efficacy of cognitive behavioral 
therapy for chronic fatigue syndrome: 
a meta-analysis. Clinical psychology 
review, 28(5), 736-745 . 2008 https://doi.
org/10.1016/j.cpr.2007.10.004
[21] Moss-Morris R, McAlpine L, 
Didsbury LP, Spence MJ. A randomized 
controlled trial of a cognitive 
behavioural therapy-based self-
management intervention for irritable 
bowel syndrome in primary care. 
Psychological medicine. 2010;40(1):85.
[22] Van Dessel, N., Den Boeft, M., 
van der Wouden, J. C., Kleinstäuber, 
M., Leone, S. S., Terluin, B., ... 
& van Marwijk, H. (2014). Non-
pharmacological interventions for 
somatoform disorders and medically 
unexplained physical symptoms 
(MUPS) in adults. Cochrane Database 
Syst Rev, 11. doi: 10.1002/14651858.
CD011142.pub2.
[23] Kroenke K, Swindle R. Cognitive-
behavioral therapy for somatization 
and symptom syndromes: a critical 
review of controlled clinical trials. 
Psychotherapy and psychosomatics. 
2000;69(4):205-15.
[24] Chavooshi B, Mohammadkhani P, 
Dolatshahee B. Telemedicine vs. 
in-person delivery of intensive short-
term dynamic psychotherapy for 
patients with medically unexplained 
pain: A 12-month randomized, 
controlled trial. Journal of telemedicine 
and telecare. 2017 Jan;23(1):133-41.
[25] Gerskowitch C, Norman I, 
Rimes KA. Patients with medically 
unexplained physical symptoms 
experience of receiving treatment in a 
primary-care psychological therapies 
service: a qualitative study. The 
Cognitive Behaviour Therapist. 2015;8.
[26] Wileman L, May C,  
Chew-Graham CA. Medically 
unexplained symptoms and the 
problem of power in the primary care 
consultation: a qualitative study. Family 
Practice. 2002 Apr 1;19(2):178-82.
[27] Unigwe, C., Rowett, M. and Udo, 
I. Reflections of the management of 
medically unexplained symptoms. 
British Journal of Psychiatry 
Bulletin,. 2014.38, 252. https://dx.doi.
org/10.1192%2Fpb.38.5.252
[28] Kellett S, Webb K, Wilkinson N, 
Bliss P, Ayers T, Hardy G. Developing 
services for patients with depression 
or anxiety in the context of long-
term physical health conditions and 
medically unexplained symptoms: 
evaluation of an IAPT pathfinder 
site. Behavioural and cognitive 
psychotherapy. 2016 Sep 1;44(5):553.
[29] Chambers JB, Marks EM,  
Russell V, Hunter MS. A multi-
disciplinary, biopsychosocial treatment 
for non-cardiac chest pain. International 
journal of clinical practice. 2015 
Sep;69(9):922-7.
23
Assessing the Effectiveness of Brief and Low Intensity Psychological Interventions for Medically…
DOI: http://dx.doi.org/10.5772/intechopen.93912
[30] Spinhoven P, Van der Does AW,  
Van Dijk E, Van Rood YR. Heart-focused 
anxiety as a mediating variable in the 
treatment of noncardiac chest pain 
by cognitive-behavioral therapy and 
paroxetine. Journal of psychosomatic 
research. 2010 Sep 1;69(3):227-35.
[31] Marchand A, Belleville G, Fleet R,  
Dupuis G, Bacon SL, Poitras J,  
Chauny JM, Vadeboncoeur A, 
Lavoie KL. Treatment of panic in 
chest pain patients from emergency 
departments: efficacy of different 
interventions focusing on panic 
management. General hospital 
psychiatry. 2012 Nov 1;34(6):671-80.
[32] George N, Abdallah J, 
Maradey-Romero C, Gerson L, Fass R. 
the current treatment of non-cardiac 
chest pain. Alimentary pharmacology & 
therapeutics. 2016 Jan;43(2):213-39.
[33] Keefe FJ, Shelby RA, Somers TJ,  
Varia I, Blazing M, Waters SJ, McKee D,  
Silva S, She L, Blumenthal JA, 
O’Connor J. Effects of coping skills 
training and sertraline in patients with 
non-cardiac chest pain: a randomized 
controlled study. PAIN®. 2011 Apr 
1;152(4):730-41.
[34] Jonsbu E, Martinsen EW, Morken G, 
Moum T, Dammen T. Change and impact 
of illness perceptions among patients 
with non-cardiac chest pain or benign 
palpitations following three sessions 
of CBT. Behavioural and cognitive 
psychotherapy. 2013 Jul;41(4):398-407.
[35] Beek, M. H. C. T., Oude Voshaar, R. 
C., Beek, A. M., Zijderveld, G. A., Visser, 
S., Speckens, A. E. M., & Balkom, A. 
J. L. M. A brief cognitive behavioural 
intervention for treating depression and 
panic disorder in patients with non-
cardiac chest pain: a 24 week randomised 
controlled trial. Depression and anxiety 
. 2013. 30(7), 670-678. https://doi.
org/10.1002/da.22106
[36] Lessard MJ, Marchand A,  
Pelland MÈ, Belleville G, 
Vadeboncoeur A, Chauny JM, Poitras J, 
Dupuis G, Fleet R, Foldes-Busque G, 
Lavoie KL. Comparing two brief 
psychological interventions to usual care 
in panic disorder patients presenting 
to the emergency department with 
chest pain. Behavioural and cognitive 
psychotherapy. 2012 Mar 1;40(2):129.
[37] Cooper, K., Gregory, J. D., Walker, 
I., Lambe, S., & Salkovskis, P. M. 
Cognitive behaviour therapy for health 
anxiety: a systematic review and meta-
analysis. 2017. Behavioural and cognitive 
psychotherapy, 45(2), 110-123. https://
doi.org/10.1017/S1352465816000527
[38] van Gils, A., Schoevers, R. A., 
Bonvanie, I. J., Gelauff, J. M., Roest, 
A. M., & Rosmalen, J. G. (2016). 
Self-help for medically unexplained 
symptoms: a systematic review and 
meta-analysis. Psychosomatic medicine. 
2016 78(6), 728-739. doi: 10.1097/
PSY.0000000000000325
[39] Tyrer, P., Cooper, S., Salkovskis, P.,  
Tyrer, H., Crawford, M., Byford, S., 
... & Murphy, D. Clinical and cost-
effectiveness of cognitive behaviour 
therapy for health anxiety in medical 
patients: a multicentre randomised 
controlled trial. The Lancet. 2014. 
383(9913), 219-225. doi: 10.1016/S0140-
6736(13)61905-4. Epub 2013 Oct 18.
[40] McDevitt-Petrovic O, Kirby K, 
Shevlin M. The prevalence of non-cardiac 
chest pain (NCCP) using emergency 
department (ED) data: a Northern 
Ireland based study. BMC health services 
research. 2017 Dec 1;17(1):549.
[41] Jonsbu E, Dammen T, Morken G, 
Moum T, Martinsen EW. Short-term 
cognitive behavioral therapy for 
non-cardiac chest pain and benign 
palpitations: a randomized controlled 
trial. Journal of psychosomatic research. 
2011 Feb 1;70(2):117-23.
[42] Avia MD, Ruiz MA, Olivares ME, 
Crespo M, Guisado AB, Sánchez A, 
Psychosomatic Medicine
24
Varela A. The meaning of psychological 
symptoms: effectiveness of a group 
intervention with hypochondriacal 
patients. Behaviour Research and 
Therapy. 1996 Jan 1;34(1):23-31.
[43] Potts SG, Lewin R, Fox KA, 
Johnstone EC. Group psychological 
treatment for chest pain with normal 
coronary arteries. Qjm. 1999 Feb 
1;92(2):81-6.
[44] Beck, A. T. Cognitive Therapy 
and the Emotional Disorders. New 




[45] Escobar JI, Gara MA,  
Diaz-Martinez AM, Interian A, 
Warman M, Allen LA, Woolfolk RL, 
Jahn E, Rodgers D. Effectiveness of 
a time-limited cognitive behavior 
therapy–type intervention among 
primary care patients with medically 
unexplained symptoms. The Annals of 
Family Medicine. 2007 Jul 1;5(4):328-35.
[46] Martin A, Rauh E, Fichter M, Rief W. 
A one-session treatment for patients 
suffering from medically unexplained 
symptoms in primary care: a randomized 
clinical trial. Psychosomatics. 2007 Jul 
1;48(4):294-303.
[47] Arnold, I. A., De Waal, M. W., 
Eekhof, J. A., Assendelft, W. J., 
Spinhoven, P., & Van Hemert, A. 
M. Medically unexplained physical 
symptoms in primary care: a controlled 
study on the effectiveness of cognitive-
behavioral treatment by the family 
physician. Psychosomatics. 2009 50(5), 
515-524. doi: 10.1176/appi.psy.50.5.515.
[48] Speckens AE, van Hemert AM, 
Bolk JH, Hawton KE, Rooijmans HG. 
The acceptability of psychological 
treatment in patients with medically 
unexplained physical symptoms. 
Journal of psychosomatic research. 1995 
Oct 1;39(7):855-63.
[49] Allen LA, Woolfolk RL, Escobar JI,  
Gara MA, Hamer RM. Cognitive-
behavioral therapy for somatization 
disorder: a randomized controlled trial. 
Archives of Internal Medicine. 2006 Jul 
24;166(14):1512-8.
[50] Aiarzaguena JM, Grandes G,  
Gaminde I, Salazar A, Sanchez A,  
Arino J. A randomized controlled 
clinical trial of a psychosocial and 
communication intervention carried 
out by GPs for patients with medically 
unexplained symptoms. Psychological 
medicine. 2007 Feb 1;37(2):283.
[51] Larisch A, Schweickhardt A, 
Wirsching M, Fritzsche K. Psychosocial 
interventions for somatizing patients 
by the general practitioner: a 
randomized controlled trial. Journal 
of psychosomatic research. 2004 Dec 
1;57(6):507-14.
[52] Katsamanis M, Lehrer PM, 
Escobar JI, Gara MA, Kotay A, Liu R. 
Psychophysiologic treatment for patients 
with medically unexplained symptoms: 
a randomized controlled trial. 
Psychosomatics. 2011 May 1;52(3):218-29.
[53] Wortman MS, Lucassen PL,  
van Ravesteijn HJ, Bor H,  
Assendelft PJ, Lucas C, Olde 
Hartman TC. Brief multimodal 
psychosomatic therapy in patients with 
medically unexplained symptoms: 
feasibility and treatment effects. Family 
practice. 2016 Aug 1;33(4):346-53.
[54] Kashner TM, Rost K, Cohen B, 
Anderson M, Smith Jr GR. Enhancing 
the health of somatization disorder 
patients: Effectiveness of short-term 
group therapy. Psychosomatics. 1995 
Sep 1;36(5):462-70.
[55] McManus F, Surawy C, Muse K,  
Vazquez-Montes M, Williams JM.  
A randomized clinical trial of 
mindfulness-based cognitive therapy 
versus unrestricted services for health 
anxiety (hypochondriasis). Journal of 
25
Assessing the Effectiveness of Brief and Low Intensity Psychological Interventions for Medically…
DOI: http://dx.doi.org/10.5772/intechopen.93912
consulting and clinical psychology. 2012 
Oct;80(5):817.
[56] McManus F, Muse K, Surawy C. 
Mindfulness-based Cognitive Therapy 
(MBCT) For Severe Health Anxiety. 
Healthcare, Counselling and 
Psychotherapy Journal. 2011:19-23.
[57] Barsky AJ, Ahern DK. Cognitive 
behavior therapy for hypochondriasis: a 
randomized controlled trial. Jama. 2004 
Mar 24;291(12):1464-70.
[58] Pelland MÈ, Marchand A,  
Lessard MJ, Belleville G, Chauny JM,  
Vadeboncoeur A, Poitras J, 
Foldes-Busque G, Bacon SL, Lavoie KL. 
Efficacy of 2 interventions for panic 
disorder in patients presenting to the ED 
with chest pain. The American journal 
of emergency medicine. 2011 Nov 
1;29(9):1051-61.
[59] Sanders D, Bass C, Mayou RA, 
Goodwin S, Bryant BM, Tyndel S. 
Non-cardiac chest pain: why was a brief 
intervention apparently ineffective?. 
Psychological medicine. 1997 Sep;27(5): 
1033-40.
[60] Esler, J. L., Barlow, D. H., Woolard, 
R. H., Nicholson, R. A., Nash, J. M., 
& Erogul, M. H. A brief cognitive-
behavioral intervention for patients 
with noncardiac chest pain. Behavior 
Therapy,. 2003 34(2), 129-148. https://
doi.org/10.1016/S0005-7894(03)80009-6
[61] Mourad G, Strömberg A, Jonsbu E, 
Gustafsson M, Johansson P, Jaarsma T. 
Guided Internet-delivered cognitive 
behavioural therapy in patients 
with non-cardiac chest pain–a pilot 
randomized controlled study. Trials. 
2016 Dec 1;17(1):352.
[62] Bahremand M, Moradi G, Saeidi M, 
Mohammadi S, Komasi S. Reducing 
irrational beliefs and pain severity in 
patients suffering from non-cardiac 
chest pain (NCCP): a comparison of 
relaxation training and metaphor 
therapy. The Korean Journal of Pain. 
2015 Apr;28(2):88.
[63] Bahremand M, Saeidi M, Komasi S. 
How effective is the use of metaphor 
therapy on reducing psychological 
symptoms and pain discomfort in 
patients with non-cardiac chest 
pain: a randomized, controlled trial. 
Journal of Cardio-Thoracic Medicine. 
2016;4(2):444-9.
[64] Smith RC, Lyles JS, Gardiner JC, et 
al: Primary care clinicians treat patients 
with medically unexplained symptoms: 
a randomized controlled trial. J Gen 
Intern Med 2006; 21:671-677
[65] Huibers MJ, Beurskens AJ, 
Bleijenberg G, et al: The effective-ness 
of psychosocial interventions delivered 
by general practitioners. Cochrane 
Database Syst Rev 2003(2):CD003494
[66] Rief W, Nanke A, Emmerich J,  
Bender A, Zech T. Causal illness 
attributions in somatoform disorders: 
associations with comorbidity 
and illness behavior. Journal of 
psychosomatic research. 2004 Oct 
1;57(4):367-71.
[67] Machin D, Campbell MJ, Tan SB, 
Tan SH. Sample sizes for clinical, 
laboratory and epidemiology studies. 
John Wiley & Sons; 2018 Aug 20.
[68] Button KS, Ioannidis JP,  
Mokrysz C, Nosek BA, Flint J,  
Robinson ES, Munafò MR. Power 
failure: why small sample size 
undermines the reliability of 
neuroscience. Nature reviews 
neuroscience. 2013 May;14(5):365-76.
[69] Coster WJ. Making the best match: 
selecting outcome measures for clinical 
trials and outcome studies. American 
Journal of Occupational Therapy. 2013 
Mar 1;67(2):162-70.
[70] Gerger H, Hlavica M, Gaab J, 
Munder T, Barth J. Does it matter who 
Psychosomatic Medicine
26
provides psychological interventions 
for medically unexplained symptoms? 
A meta-analysis. Psychotherapy and 
Psychosomatics. 2015;84(4):217-26.
[71] Burton C. Beyond somatisation: 
a review of the understanding and 
treatment of medically unexplained 
physical symptoms (MUPS). British 
Journal of General Practice. 2003 Mar 
1;53(488):231-9.
[72] Morriss R, Dowrick C, Salmon P, 
Peters S, Dunn G, Rogers A, Lewis B, 
Charles-Jones H, Hogg J, Clifford R, 
Rigby C. Cluster randomised controlled 
trial of training practices in 
reattribution for medically unexplained 
symptoms. The British Journal of 
Psychiatry. 2007 Dec;191(6):536-42.
[73] Looper KJ, Kirmayer LJ. Behavioral 
medicine approaches to somatoform 
disorders. Journal of consulting and 
clinical psychology. 2002 Jun;70(3):810.
[74] Smith, R. C., Lein, C., Collins, C.,  
Lyles, J. S., Given, B., Dwamena, 
F. C., ... & Given, C. W. Treating 
patients with medically unexplained 
symptoms in primary care. Journal 
of General Internal Medicine, 18 
2003. (6), 478-489. https://doi.
org/10.1046/j.1525-1497.2003.20815.x
[75] Williams GC, Halvari H, 
Niemiec CP, Sørebø Ø, Olafsen AH, 
Westbye C. Managerial support for basic 
psychological needs, somatic symptom 
burden and work-related correlates: A 
self-determination theory perspective. 
Work & Stress. 2014 Oct 2;28(4):404-19.
